Teva Pharmaceuticals USA

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Teva Pharmaceuticals USA sits in the top decile of US sponsors by registered trial count (#271 of 15,751 sponsors by registered trial count).

83 total trials none currently recruiting 81 completed early-phase tilt top decile by trial count

Teva Pharmaceuticals USA: 83 sponsored US clinical trials, none currently recruiting.

Teva Pharmaceuticals USA sponsors 83 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 81 completed. 7 of these trials are in Phase 3-4 (later-stage) and 76 in Phase 1-2 (earlier-stage).

Top-decile sponsor footprint

Teva Pharmaceuticals USA ranks in the top decile of sponsors by registered trial count (#271 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

83 total, page 1 of 2

COMPLETED Phase 3

Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis

NCT06742957
COMPLETED Phase 3

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

NCT05617820
COMPLETED Phase 3

Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris

NCT05550337
COMPLETED Phase 3

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

NCT04729621
COMPLETED Phase 3

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

NCT02611804
TERMINATED Phase 3

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

NCT02246920
COMPLETED Phase 3

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

NCT01686152
TERMINATED Phase 1

Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

NCT01046214
COMPLETED Phase 1

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

NCT01344369
COMPLETED Phase 1

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions

NCT01157169
COMPLETED Phase 1

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

NCT01182636
COMPLETED Phase 1

Levetiracetam 1000 mg Under Fasting Conditions

NCT00859521
COMPLETED Phase 1

Levetiracetam 1000 mg Under Non-Fasting Conditions

NCT00859430
COMPLETED Phase 1

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

NCT00911274
COMPLETED Phase 1

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

NCT00910663
COMPLETED Phase 1

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions

NCT00829764
COMPLETED Phase 1

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions

NCT00829790
COMPLETED Phase 1

Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions

NCT00974441
COMPLETED Phase 1

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

NCT01182194
COMPLETED Phase 1

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

NCT01260948
COMPLETED Phase 1

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

NCT00830206
COMPLETED Phase 1

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

NCT00830336
COMPLETED Phase 1

Cefdinir Capsules 300 mg, Non-fasting

NCT00834535
COMPLETED Phase 1

Cefdinir Capsules 300 mg, Fasting

NCT00835484
COMPLETED Phase 1

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions

NCT00829426
COMPLETED Phase 1

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

NCT00835549
COMPLETED Phase 1

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

NCT00829309
COMPLETED Phase 1

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

NCT00834574
COMPLETED Phase 1

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

NCT01074463
COMPLETED Phase 1

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions

NCT01074450
COMPLETED Phase 1

The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions

NCT00830219
COMPLETED Phase 1

Ropinirole 0.25 mg Tablets Under Fasting Conditions

NCT00829504
COMPLETED Phase 1

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

NCT00846885
COMPLETED Phase 1

Famciclovir 500 mg Tablets Under Non-Fasting Conditions

NCT00834444
COMPLETED Phase 1

Famciclovir 500 mg Tablets Under Fasting Conditions

NCT00834431
COMPLETED Phase 1

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

NCT00829673
COMPLETED Phase 1

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting

NCT00835497
COMPLETED Phase 1

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

NCT00829712
COMPLETED Phase 1

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting

NCT00834587
COMPLETED Phase 1

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

NCT00835354
COMPLETED Phase 1

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

NCT01149473
COMPLETED Phase 1

Zaleplon 10mg Capsules Under Fasting Conditions

NCT00829998
COMPLETED Phase 1

Zaleplon 10 mg Capsules Under Non-Fasting Conditions

NCT00829868
COMPLETED Phase 1

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

NCT01149486
COMPLETED Phase 1

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

NCT01046253
COMPLETED Phase 1

Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions

NCT00835588
COMPLETED Phase 1

Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

NCT00835393
COMPLETED Phase 1

Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

NCT00835042
COMPLETED Phase 1

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

NCT00834067
COMPLETED Phase 1

Cefprozil 500 mg Tablets Under Fasting Conditions

NCT00840281
Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 76
Phase 3 7

How the Teva Pharmaceuticals USA early-phase archive is shaped

83 indexed studies, none listed as recruiting (0% open); 81 completed (98%).

Phase mix: 7 late (III/IV) vs 76 early (I/II) (early-phase heavy).

Therapeutic area indexing for this sponsor is limited in the public registry.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.